Pulmonary rehabilitation is of unquestioned benefit to COPD patients. The scientific basis of this therapy is firmly established. Yet it is available to a very small fraction of those who would benefit from it. In the cases of smoking cessation and inhaled bronchodilators, forces have been brought to bear to impact the vast majority of COPD patients. This lecture will examine the reasons for this discrepancy and suggest a way forward.

**Please note that all programs require the participant to view the entire program prior to taking the final quiz and obtaining a course certificate.**